If youre looking into GLP-1 medications for weight loss, youve probably come across two big names: semaglutide and tirzepatide
Semaglutide (Ozempic/Wegovy) shows 3-year efficacy for blood sugar control and weight loss Data from a real world study indicates that treatment with the semaglutide (Ozempic/Wegovy) for type 2 diabetes significantly improves both blood sugar control and weight loss for up to 3 years in adults
as of 2024, it has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for use in the United Kingdom or European Union
What is the difference between Semaglutide GLP-1, Ozempic, Wegovy and Mounjaro
TRIUMPH-5 and TRIUMPH-6 TRIUMPH-5 is an active-comparator trial in type 2 diabetes, benchmarking retatrutide against an existing GLP-1 rather than placebo
To get the most out of these medications, its essential to pair them with consistent nutrition, movement, and support